Log In
BCIQ
Print this Print this
 

Interleukin-3 (IL-3) receptor alpha (CD123)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-3 (IL-3) receptor alpha (CD123)

BCIQ
Print ChartPrint this
1 - Cancer 6 - Cancer 3 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase II
Cancer

3

6

1




 Products Targeting Interleukin-3 (IL-3) receptor alpha (CD123)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$2,550.0M

$150.0M

$2,400.0M


 Deals Details
Get a free BioCentury Trial today